Disclosure under Regulation 29(2) of SEBI (SAST) Regulations, 2011 and Regulation 7(2) of SEBI (PIT) Regulations, 2015. Promoter entity (Tenshi Pharmaceuticals Private Limited), has purchased 2,00,000 equity shares of the Company from the market on January 28,2026.